Abstract: The invention relates to the crystalline form of the hydrochloride of the compound (R)-(-)-2-{N-?4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl! -aminomethyl}-chroman, which is present as a stable form at room temperature. The crystalline modification V of the hydrochloride is suitable in particular for the preparation of solid medicaments, in particular of medicaments for the treatment of neuronal degenerations.
Type:
Grant
Filed:
November 19, 1996
Date of Patent:
November 3, 1998
Assignee:
Bayer Aktiengesellschaft
Inventors:
Alfons Grunenberg, Oliver Brehm, Michael Conrad, Dietrich Seidel